Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shawn Cross Insider Profile
4 Followers
Shawn Cross, CEO & Chair of the Board, Director at Applied Molecular Transport, holds 107.75K shares in Cyclo Therapeutics (Ticker: CYTH), holds 75.00K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 545.50K shares in Applied Molecular Transport (Ticker: AMTI).
Shawn Cross Applied Molecular Transport (AMTI)CEO & Chair of the Board, Director
Applied Molecular Transport (AMTI)
CEO & Chair of the Board, Director
Ranked #10,381 out of 100,202 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+85.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Shawn Cross holds in companies
Most Profitable Insider Trade
Stock:
Applied Molecular Transport
(AMTI)
(AMTI)
Rating:Informative Sell
Date:Jun 03, 2022 - Jun 03, 2023
Return:+92.30%
The most profitable trade made by Shawn Cross
Shawn Cross's Trading History
Applied Molecular Transport
Nov 24, 2023
―
Informative Sell
17.73K
$143.47K
Cyclo Therapeutics
Nov 18, 2024
Director
Uninformative Buy
―
$67.88K
Pacira Pharmaceuticals
Nov 05, 2024
Chief Financial Officer
Uninformative Buy
―
$1.42M
List of latest transactions for each holding click on a transaction to see Shawn Cross's performance on stock
You May Also Like
Shawn Cross insider profile FAQ
What is the percentage of profitable transactions made by Shawn Cross?
The percentage of profitable transactions made by Shawn Cross is 100%.
What is the average return per transaction made by Shawn Cross?
The average return per transaction made by Shawn Cross is 85.80%.
What stocks does Shawn Cross hold?
Shawn Cross holds: AMTI, CYTH, PCRX stocks.
What was Shawn Cross’s latest transaction?
Shawn Cross latest transaction was an Uninformative Buy of ―.
What was Shawn Cross's most profitable transaction?
Shawn Cross’s most profitable transaction was an Informative Sell of AMTI stock on June 3, 2022. The return on the trade was 92.30%.
What is Shawn Cross's role in Applied Molecular Transport?
Shawn Cross's role in Applied Molecular Transport is CEO & Chair of the Board, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.